Text Module


Share

Program Content

Activities

  • Role of the MDM2-p53 Pathway in BTC
    Targeting the MDM2-p53 Pathway in Biliary Tract Cancer: Emerging Data and Implications for Future Clinical Practice
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 29, 2024

    Expires: February 28, 2025

Faculty

cover img faculity

Patricia LoRusso, DO, PhD(h)

Associate Center Director, Experimental Therapeutics
Director, Early Phase Clinical Trials Program
Yale Cancer Center
Yale University
New Haven, Connecticut

PT Faculty

cover img faculity

Timothy Scialla, MD

Associate Professor
Division of Pulmonary, Allergy, and Critical Care Medicine
Department of Medicine
University of Virginia School of Medicine
Charlottesville, Virginia

cover img faculity

Chetasi Talati, MD

Assistant Professor
Department of Oncologic Sciences
Assistant Member
Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida

cover img faculity

Jill Taylor

Contributing Writer

cover img faculity

Ashutosh Wechalekar, MBBS, MD, FRCP, FRCPath, DM

Professor of Medicine and Haematology
University College London
Honorary Consultant Haemetologist
University College Hospitals
Director, Jack O’Neil Laboratory
Department of Haematology
National Amyloidosis Centre
London, United Kingdom

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.